B. Séguin, N. F. Leibman, V. S. Bregazzi, G. K. Ogilvie, B. E. Powers, W. S. Dernell, M. J. Fettman and S. J. Withrow, “Clinical Outcome of Dogs with Grade II Mast Cell Tumors Treated with Surgery Alone: 55 Cases (1996-1999),” Journal of the American Veterinary Medical Association, Vol. 218, No. 7, 2001, pp. 1120-1123. doi:10.2460/javma.2001.218.1120
 G. M. Michels, D. W. Knapp, D. B. Denicola, N. Glickman and P. Bonney, “Prognosis Following Surgical Excision of Canine Cutaneous Mast Cell Tumors with histopathologically Tumor-Free Versus Nontumor-Free Margins: A Retrospective Study of 31 Cases,” Journal of the American Animal Hospital Association, Vol. 38, No. 5, 2002, pp. 458-466.
 V. M. D. C. Weisse and C. M. V. K. Sorenmo, “Recurrence Rates and Sites for Grade II Canine Cutaneous Mast Cell Tumors Following Complete Surgical Excision,” Journal of the American Animal Hospital Association, Vol. 38, No. 1, 2002, pp. 71-73.
 J. J. Abadie, M. A. Amardeilh and M. E. Delverdier, “Immunohistochemical Detection of Proliferating Cell Nuclear Antigen and Ki-67 in Mast Cell Tumors from Dogs,” Journal of the American Animal Hospital Association, Vol. 215, No. 11, 1999, pp. 1629-1634.
 H. Sakai, A. Noda, N. Shirai, et al., “Proliferative Activity of Canine Mast Cell Tumours Evaluated by Bromodeoxyuridine Incorporation and Ki-67 Expression,” Journal of Comparative Pathology, Vol. 127, No. 4, 2002, pp. 233-238. doi:10.1053/jcpa.2002.0586
 J. P. Simoes, P. Schoning and M. Butine, “Prognosis of Canine Mast Cell Tumors: A Comparison of Three Methods,” Veterinary Pathology, Vol. 31, No. 6, 1994, pp. 637-647. doi:10.1177/030098589403100602
 L. D. Kravis, D. M. Vail, W. C. Kissebert, et al., “Frequency of Argyrophilic Nucleolar Organizer Regions in Fine-Needle Aspirates and Biopsy Specimens from Mast Cell Tumors in Dogs,” Journal of the American Veterinary Medical Association, Vol. 209, No. 8, 1996, pp. 1418-1420.
 R. D. Ayl, C. G. Couto, A. S. Hammer, S. Weisbrode, J. G. Ericson and L. Mathes, “Correlation of DNA Ploidy to Tumor Histologic Grade, Clinical Variables, and Survival in Dogs with Mast Cell Tumors,” Veterinary Pathology, Vol. 29, No. 5, 1992, pp. 386-390. doi:10.1177/030098589202900503
 R. Preziosi, G. Sarli and M. Paltrinieri, “Prognostic Value of Intratumoral Vessel Density in Cutaneous Mast Cell Tumors of the Dog,” Journal of Comparative Pathology, Vol. 130, No. 2-3, 2004, pp. 143-151. doi:10.1016/j.jcpa.2003.10.003
 P. E. Ginn, L. E. Fox, J. C. Brower, A. Gaskin, I. D. Kurzman and P. S. Kubilis, “Immunohistochemical Detection of p53 Tumor-Suppressor Protein Is a Poor Indicator of Prognosis for Canine Cutaneous Mast Cell Tumors,” Veterinary Pathology, Vol. 37, No. 1, 2000, pp. 33-39. doi:10.1354/vp.37-1-33
 M. H. Jaffe, G. Hosgood, H. W. Taylor, S. C Kerwin, C. S. Hedlund, M. K. Lopez, J. R. Davidson, D. M. Miller and M. Paranjpe, “Immunohistochemical and Clinical Evaluation of p53 in Canine Cutaneous Mast Cell Tumors,” Veterinary Pathology, Vol. 37, No. 1, 2000, pp. 40-46. doi:10.1354/vp.37-1-40
 M. Kiupel, J. D. Webster, J. B. Kaneene, et al., “The Use of KIT and Tryptase Expression Patterns as Prognostic Tools for Canine Cutaneous Mast Cell Tumors,” Veterinary Pathology, Vol. 41, No. 4, 2004, pp. 371-377. doi:10.1354/vp.41-4-371
 J. D. Webster, V. Yuzbasiyan-Gurkan, J. B. Kaneene, et al., “The Role of c-KIT in Tumorigenesis: Evaluation in Canine Cutaneous Mast Cell Tumors,” Neoplasia, Vol. 8, No. 2, 2006, pp. 104-111. doi:10.1593/neo.05622
 M. Kiupel, J. D. Webster, R. A. Miller and J. B. Kaneene, “Impact of Tumour Depth, Tumour Location and Multiple Synchronous Masses on the Prognosis of CANINE cutaneous Mast Cell Tumours,” Journal of Veterinary Medicine Series A, Vol. 52, No. 6, 2005, pp. 280-286. doi:10.1111/j.1439-0442.2005.00726.x
 A. K. Cahalane, S. Payne, L. G. Barber, et al., “Prognostic Factors for Survival of Dogs with Inguinal and Perineal Mast Cell Tumors Treated Surgically with or without Adjunctive Treatment: 68 Cases (1994-2002),” Journal of the American Veterinary Medical Association, Vol. 225, No. 3, 2004, pp. 401-408. doi:10.2460/javma.2004.225.401
 S. S. Raab, R. E. Nakhleh and S. G. Ruby, “Patient Safety in Anatomic Pathology: Measuring Discrepancy Frequencies and Causes,” Archives of Pathology & Laboratory Medicine, Vol. 129, No. 4, 2005, pp. 459-466.
 S. S. Raab, D. M. Grzybicki, J. E. Janosky et al., “Clinical Impact and Frequency of Anatomic Pathology Erros in Cancer Diagnosis,” American Cancer Society, Vol. 104, No. 10, 2005, pp. 2205-2213.
 K. Lindblad-Toh, C. M. Wade, T. S. Mikkelsen, E. K. Karlsson, D. B. Jaffe, M. Kamal, M. Clamp, J. L. Chang, E. J. Kulbokas, M. C. Zody, et al., “Genome Sequence, Comparative Analysis and Haplotype Structure of the Domestic Dog,” Nature, Vol. 438, No. 7069, 2005, pp. 803-819. doi:10.1038/nature04338
 M. H. Goldschmidt and M. J. Hendrick, “Tumors of the Skin and Soft Tissues,” In: D. J. Meuten, “Tumors in Domestic Animals,” 4th Edition, Iowa State Press, Iowa, 2002, pp. 105-107. doi:10.1002/9780470376928.ch2
 J. M. Cullen, R. Page and W. Misdorp, “An Overview of Cancer Pathogenesis, Diagnosis, and Management,” In: D. J. Meuten, “Tumors in Domestic Animals,” 4th Edition, Iowa State Press, Iowa, 2002, pp. 3-27.